Last reviewed · How we verify

Isopropamid (ISOPROPAMIDE)

GSK · FDA-approved approved Small molecule Quality 30/100

Isopropamide, also known as ISOPROPAMIDE, is a small molecule drug developed by GlaxoSmithKline that targets the muscarinic acetylcholine receptor M1. It was approved by the FDA in 1957 for the treatment of peptic ulcers. As an off-patent medication, it is no longer protected by active patents, and there are currently no generic manufacturers. Isopropamide works by stimulating the muscarinic receptors in the stomach, which helps to increase the movement of food through the digestive system and reduce stomach acid production. It is a medication that has been used for many years to treat peptic ulcers.

At a glance

Generic nameISOPROPAMIDE
SponsorGSK
Drug classisopropamide
TargetMuscarinic acetylcholine receptor M1
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved
First approval1957

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions